HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peng Sun Selected Research

Lymphoma (Lymphomas)

1/2024Dual-Layer Spectral Detector Computed Tomography Quantitative Parameters: A Potential Tool for Lymph Node Activity Determination in Lymphoma Patients.
1/2023A phase II study of sintilimab, anlotinib, and pegaspargase sandwiched with radiotherapy as first-line therapy in patients with newly diagnosed, stage I-II extranodal natural-killer/T-cell lymphoma.
1/2022Phase II Study of Gemcitabine, Peg-Asparaginase, Dexamethasone and Methotrexate Regimen for Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Final Analysis With Long-Term Follow-Up and Rational Research for the Combination.
1/2022Combination of Anti-PD-1 Antibody, Anlotinib and Pegaspargase "Sandwich" With Radiotherapy in Localized Natural Killer/T Cell Lymphoma.
12/2021Combined tumor-associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma.
9/2021Elevated expression of HMGB1 is prognostic of poor survival in patients with relapsed/refractory T/NK-CL.
1/2019Mutation Profiling of Malignant Lymphoma by Next-Generation Sequencing of Circulating Cell-Free DNA.
1/2019High-dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China.
6/2016High risk of deep vein thrombosis associated with peripherally inserted central catheters in lymphoma.
4/2016Consolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peng Sun Research Topics

Disease

198Neoplasms (Cancer)
04/2024 - 10/2003
47Inflammation (Inflammations)
03/2024 - 01/2013
42Infections
04/2024 - 04/2003
40Neoplasm Metastasis (Metastasis)
04/2024 - 03/2010
23Breast Neoplasms (Breast Cancer)
03/2024 - 04/2014
19Stomach Neoplasms (Stomach Cancer)
10/2023 - 11/2012
16Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 01/2013
15Insulin Resistance
01/2024 - 01/2013
15Body Weight (Weight, Body)
01/2024 - 06/2011
14Prostatic Neoplasms (Prostate Cancer)
01/2024 - 06/2009
14Hepatocellular Carcinoma (Hepatoma)
01/2024 - 10/2003
14Glioma (Gliomas)
12/2023 - 12/2009
13Hypoxia (Hypoxemia)
04/2024 - 01/2013
13Lymphoma (Lymphomas)
01/2024 - 07/2015
12Wounds and Injuries (Trauma)
03/2024 - 01/2014
12Melanoma (Melanoma, Malignant)
11/2023 - 08/2012
11Type 2 Diabetes Mellitus (MODY)
01/2024 - 01/2015
11Ischemia
04/2023 - 12/2008
11Nasopharyngeal Carcinoma
01/2022 - 09/2013
11Carcinogenesis
01/2022 - 08/2012
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 01/2015
10Diarrhea
10/2023 - 09/2008
9Carcinoma (Carcinomatosis)
03/2024 - 12/2009
9Colonic Neoplasms (Colon Cancer)
04/2023 - 02/2014
9Hemorrhage
01/2023 - 03/2012
9Neointima
12/2022 - 01/2020
9Hyperplasia
12/2022 - 07/2014
8Lung Neoplasms (Lung Cancer)
04/2024 - 01/2016
8Triple Negative Breast Neoplasms
03/2024 - 06/2019
8Heart Arrest (Cardiac Arrest)
12/2023 - 04/2015
8Pain (Aches)
12/2023 - 01/2014
8Ischemic Stroke
11/2023 - 08/2013
8Reperfusion Injury
04/2023 - 12/2008
8Disease Progression
01/2023 - 11/2014
8COVID-19
07/2022 - 01/2020
7Fever (Fevers)
05/2024 - 04/2009
7Stroke (Strokes)
11/2023 - 10/2010
7Osteoarthritis
05/2023 - 10/2019
7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023 - 07/2016
7Esophageal Squamous Cell Carcinoma
12/2017 - 08/2013
6Liver Cirrhosis (Hepatic Cirrhosis)
04/2024 - 01/2007
6Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2024 - 10/2011
6Traumatic Brain Injuries (Traumatic Brain Injury)
03/2024 - 11/2016
6Sepsis (Septicemia)
01/2024 - 12/2016
6Necrosis
01/2024 - 11/2013
6Obesity
01/2024 - 05/2014
6Squamous Cell Carcinoma of Head and Neck
12/2023 - 01/2017
6Lymphatic Metastasis
12/2023 - 10/2020
6Glioblastoma (Glioblastoma Multiforme)
12/2023 - 07/2009
6Thyroid Neoplasms (Thyroid Cancer)
06/2023 - 12/2018

Drug/Important Bio-Agent (IBA)

73Proteins (Proteins, Gene)FDA Link
04/2024 - 10/2003
42Biomarkers (Surrogate Marker)IBA
04/2024 - 08/2009
30Messenger RNA (mRNA)IBA
01/2024 - 06/2005
20Therapeutic UsesIBA
04/2024 - 08/2007
20LipidsIBA
01/2024 - 12/2009
19Glucose (Dextrose)FDA LinkGeneric
01/2024 - 03/2011
16CytokinesIBA
01/2024 - 09/2013
14HydrogelsIBA
03/2024 - 12/2013
13VaccinesIBA
04/2024 - 05/2012
12MicroRNAs (MicroRNA)IBA
03/2024 - 09/2014
12EnzymesIBA
01/2024 - 06/2014
11Long Noncoding RNAIBA
02/2024 - 01/2016
11Small Interfering RNA (siRNA)IBA
09/2023 - 02/2010
11Indicators and Reagents (Reagents)IBA
04/2021 - 08/2013
10AntioxidantsIBA
03/2024 - 01/2014
10Peptides (Polypeptides)IBA
02/2024 - 06/2012
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 02/2010
9Interleukin-6 (Interleukin 6)IBA
01/2024 - 10/2011
9RNA (Ribonucleic Acid)IBA
10/2023 - 01/2017
9Insulin (Novolin)FDA Link
05/2023 - 01/2013
9Phosphotransferases (Kinase)IBA
01/2022 - 11/2009
8Anti-Bacterial Agents (Antibiotics)IBA
12/2023 - 11/2009
8Proliferating Cell Nuclear Antigen (PCNA)IBA
12/2022 - 04/2003
8Cisplatin (Platino)FDA LinkGeneric
01/2021 - 01/2014
8Caspase 3 (Caspase-3)IBA
01/2020 - 11/2013
8Matrix Metalloproteinases (MMPs)IBA
09/2018 - 08/2013
8trametinibIBA
03/2016 - 08/2012
7Transcription Factors (Transcription Factor)IBA
04/2024 - 01/2018
7Polysaccharides (Glycans)IBA
04/2024 - 04/2014
7CateninsIBA
06/2023 - 07/2014
7Immune Checkpoint InhibitorsIBA
03/2023 - 02/2020
7DNA (Deoxyribonucleic Acid)IBA
01/2023 - 10/2003
7Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2023 - 08/2012
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2022 - 11/2012
7Ethanol (Ethyl Alcohol)IBA
09/2022 - 03/2016
7Bevacizumab (Avastin)FDA Link
11/2018 - 12/2011
7dabrafenibIBA
03/2016 - 11/2012
6InterleukinsIBA
01/2024 - 09/2013
6AlbuminsIBA
01/2024 - 01/2016
6LipopolysaccharidesIBA
09/2023 - 01/2013
6Circular RNAIBA
07/2023 - 01/2019
6Glycoproteins (Glycoprotein)IBA
05/2023 - 04/2009

Therapy/Procedure

71Therapeutics
04/2024 - 06/2009
23Drug Therapy (Chemotherapy)
11/2023 - 03/2010
17Radiotherapy
04/2024 - 03/2010
13Immunotherapy
03/2024 - 01/2020
10Cardiopulmonary Resuscitation (CPR)
12/2023 - 04/2015
10Aftercare (After-Treatment)
06/2023 - 04/2003
9Length of Stay
05/2024 - 03/2015
9Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2023 - 03/2005